Wound Treatments in Switzerland
Euromonitor International's Wound Treatments in Switzerland market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 35 | Publication date: Apr 2009
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Other wound treatments; Sticking plasters
Table of contents
WOUND TREATMENTS IN SWITZERLAND : MARKET INSIGHT
TRENDS
SECTOR DATA
Table 1 Sales of Wound Treatments by Subsector: Value 2003-2008
Table 2 Sales of Wound Treatments by Subsector: % Value Growth 2003-2008
Table 3 Wound Treatments Company Shares by Value 2004-2008
Table 4 Wound Treatments Brand Shares by Value 2005-2008
Table 5 Forecast Sales of Wound Treatments by Subsector: Value 2008-2013
Table 6 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2008-2013
LOCAL COMPANY PROFILES - SWITZERLAND
BIOFORCE AG - OTC HEALTHCARE - SWITZERLAND
STRATEGIC DIRECTION
KEY FACTS
Summary 1 Bioforce AG: Key Facts
Summary 2 Bioforce AG: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 3 Bioforce AG: Production Statistics 2008
COMPETITIVE POSITIONING
Summary 4 Bioforce AG: Competitive Position 2008
IVF HARTMANN AG - OTC HEALTHCARE - SWITZERLAND
STRATEGIC DIRECTION
KEY FACTS
Summary 5 IVF Hartmann AG: Key Facts
Summary 6 IVF Hartmann AG: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 7 IVF Hartmann AG: Competitive Position 2008
SPIRIG PHARMA AG - OTC HEALTHCARE - SWITZERLAND
STRATEGIC DIRECTION
KEY FACTS
Summary 8 Spirig Pharma AG: Key Facts
Summary 9 Spirig Pharma AG: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 10 Spirig Pharma AG: Production Statistics 2007
COMPETITIVE POSITIONING
Summary 11 Spirig Pharma AG: Competitive Position 2008
STREULI PHARMA AG - OTC HEALTHCARE - SWITZERLAND
STRATEGIC DIRECTION
KEY FACTS
Summary 12 Streuli Pharma AG: Key Facts
Summary 13 Streuli Pharma AG: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 14 Streuli Pharma AG: Competitive Position 2008
VIFOR FRIBOURG SA - OTC HEALTHCARE - SWITZERLAND
STRATEGIC DIRECTION
KEY FACTS
Summary 15 Vifor Pharma: Key Facts
Summary 16 Vifor Pharma: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 17 Vifor Pharma: Competitive Position 2008
OTC HEALTHCARE IN SWITZERLAND
EXECUTIVE SUMMARY
Healthy market performance experienced in 2008
Key market drivers in the Swiss OTC healthcare market
Roche Pharma leads Switzerland OTC Healthcare market
Share of grocery retailers increases
Positive but slow constant value growth expected
KEY TRENDS AND DEVELOPMENTS
Emphasis on healthy diets and lifestyle behaviour
Rising healthcare cost drives more self-medication
Population is ageing and women are having fewer children
Changes in weather patterns affect allergy sufferers
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 8 Life Expectancy at Birth 2003-2008
MARKET DATA
Table 9 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 10 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 11 OTC Healthcare Company Shares by Value 2004-2008
Table 12 OTC Healthcare Brand Shares by Value 2005-2008
Table 13 Penetration of Private Label by Sector 2003-2008
Table 14 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 15 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 16 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 17 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
APPENDIX
OTC Registration and Classification
Vitamins & Dietary Supplements Registration and Classification
EU Legislation
Self-medication and Preventive Medicine
Generics
Switches
DEFINITIONS
Summary 18 Research Sources